| 000 | 01507 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513233015.0 | ||
| 264 | 0 | _c20010412 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(00)00449-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOzenci, V | |
| 245 | 0 | 0 |
_aIL-12/IL-12R system in multiple sclerosis. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cMar 2001 |
||
| 300 |
_a242-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-12 _xcerebrospinal fluid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aPhytohemagglutinins _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Interleukin _ximmunology |
| 650 | 0 | 4 | _aReceptors, Interleukin-12 |
| 650 | 0 | 4 |
_aTh1 Cells _xdrug effects |
| 650 | 0 | 4 |
_aTh2 Cells _xdrug effects |
| 700 | 1 | _aPashenkov, M | |
| 700 | 1 | _aKouwenhoven, M | |
| 700 | 1 | _aRinaldi, L | |
| 700 | 1 | _aSöderström, M | |
| 700 | 1 | _aLink, H | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 114 _gno. 1-2 _gp. 242-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(00)00449-5 _zAvailable from publisher's website |
| 999 |
_c11177194 _d11177194 |
||